Management of alloimmune thrombocytopenia.
Kanhai
H H H
HH
Department of Obstetrics, Leiden University Medical Center, Leiden, The Netherlands. h.h.h.kanhai@lumc.nl
Porcelijn
L
L
Engelfriet
C P
CP
Reesink
H W
HW
Panzer
S
S
Ulm
B
B
Goldman
M
M
Bonacossa
I
I
Richard
L
L
David
M
M
Taaning
E
E
Hedegaard
M
M
Kaplan
C
C
Kiefel
V
V
Meyer
O
O
Salama
A
A
Morelati
F
F
Greppi
N
N
Marconi
M
M
Tassis
B
B
Tsuno
N H
NH
Takahashi
K
K
Oepkes
D
D
Porcelijn
L
L
Kanhai
H
H
Osnes
L T N
LT
Husebekk
A
A
Killie
M K
MK
Kjeldsen-Kragh
J
J
Zupanska
B
B
Muñiz-Diaz
E
E
Nogués
N
N
Parra
J
J
Urbaniak
S J
SJ
Cameron
A
A
D016824:Antigens, Human Platelet / Q000097:blood / Q000276:immunology*; D005260:Female; D006801:Humans; D016756:Immunoglobulins, Intravenous / Q000627:therapeutic use; D007231:Infant, Newborn; D039661:Integrin beta3; D010641:Phenotype; D017713:Platelet Transfusion; D017410:Practice Guidelines as Topic; D011247:Pregnancy; D011295:Prenatal Care / Q000379:methods; D054098:Thrombocytopenia, Neonatal Alloimmune / Q000175:diagnosis* / Q000628:therapy*
D016824:Antigens, Human Platelet; C061248:ITGB3 protein, human; D016756:Immunoglobulins, Intravenous; D039661:Integrin beta3